Gibbons v. GlaxoSmithKline, LLC et al
Consolidated
Lead case: 9:20-md-02924
Lead case: 9:20-md-02924
| Florida Southern District Court | |
| Judge: | Robin L Rosenberg |
| Case #: | 9:21-cv-80236 |
| Nature of Suit | 365 Torts - Personal Injury - Product Liability |
| Cause | 28:1332 Diversity-Personal Injury |
| Case Filed: | Feb 02, 2021 |
| Terminated: | Feb 16, 2021 |
| Case in other court: | California Northern, 3:21-cv-00442 |
| Last checked: Sunday Aug 01, 2021 4:53 AM EDT |
|
Defendant
Boehringer Ingelheim Pharmaceuticals Inc.
|
Represented By
|
|
Defendant
Boehringer Ingelheim USA Corporation, Inc.
|
Represented By
|
|
Defendant
GlaxoSmithKline LLC
|
Represented By
|
|
Defendant
Grocery Outlet
|
|
|
Defendant
Safeway Health, Inc.
|
|
|
Defendant
Safeway Inc.
|
|
|
Defendant
Sanofi US Services Inc.
|
Represented By
|
|
Defendant
Sanofi-Aventis U.S. LLC
|
Represented By
|
|
Plaintiff
Nathan Gibbons
|
Represented By
|
| Docket last updated: 11 hours ago |
| Thursday, February 25, 2021 | ||
| 28 | 28
misc
MDL Transmittal Letter Requesting/Sending Case
Fri 02/26 3:46 PM
Transmittal Letter Sent with Order Remanding Case to: Superior Court for the State of California County of Alameda. State Court Case Number: 3:21-cv-00442 (mc) |
|
| 27 | 27
4
pgs
order
Order Remanding Case to State Court
Fri 02/26 1:19 PM
ORDER granting (2569, 2740 in case 9:20-md-02924-RLR) Plaintiffs' Motion to Remand Cases to California State Court. Signed by Judge Robin L. Rosenberg on 2/25/2021. Related Cases: 9:20-md-02924-RLR, 9:21-cv-80236-RLR. See attached document for full details. (mc) |
|
| Tuesday, February 16, 2021 | ||
| 26 | 26
order
Administrative Order
Tue 02/16 5:09 PM
ORDER OF CONSOLIDATION AND ADMINISTRATIVE CLOSE-OUT. Signed by Judge Robin L. Rosenberg on 2/16/2021. See attached document for full details. (mc) |
|
| Tuesday, February 02, 2021 | ||
| 25 | 25
transfer
MDL Tag-Along/Transfer In Case Receipt
Tue 02/02 8:35 AM
MDL Transfer In Case Receipt from Northern District of California. Case Number 3:21-cv-00442 with documents 1-22. Assigned FLSD Case Number 9:21-cv-80236-RLR on 2/2/2021. Re: FLSD MDL Case Number 9:20-md-02924-RLR. (mc) |
|
| 24 | 24
order
Clerk's Notice of Judge Assignment and Optional Consent
Tue 02/02 8:06 AM
Clerks Notice of Judge Assignment to Judge Robin L. Rosenberg. (mc) |
|
| 23 | 23
transfer
Case Transferred In - District Transfer - CV - NO FEE
Tue 02/02 8:03 AM
Case transferred in from California Northern; Case Number 3:21-cv-00442. Electronic file including transfer order and docket sheet received. .(mc) |
|
| Friday, January 29, 2021 | ||
| 22 | 22
CONDITIONAL TRANSFER ORDER (CTO-52) by MDL Panel TRANSFERRING CASE to the Southern District of Florida. (slhS, COURT STAFF)
|
|
| 21 | 21
STIPULATION Stipulation to Extend Time to Answer or Otherwise Respond to Complaint filed by Sanofi US Services, Inc., Sanofi-Aventis U.S. LLC. (Mayo, Sharon)
|
|
| Thursday, January 21, 2021 | ||
| 20 | 20
Amended MOTION to Stay re5 MOTION to Stay Proceedings Pending Transfer to the MDL filed by Boehringer Ingelheim Pharmaceuticals, Inc., Boehringer Ingelheim USA Corporation, Inc., GlaxoSmithKline, LLC, Sanofi US Services, Inc., Sanofi-Aventis U.S. LLC. Motion Hearing set for 2/26/2021 10:00 AM before Judge Susan Illston. Responses due by 2/2/2021. Replies due by 2/9/2021.(Tam, Jonathan)
|
|
|
Att: 1
Proposed Order
|
||
| 19 | 19
INITIAL CASE MANAGEMENT GUIDELINE AND CLERK'S NOTICE ON REASSIGNMENT. Initial Case Management Conference set for 4/23/2021 at 02:30 PM in San Francisco, Courtroom 01, 17th Floor. Joint Case Management Statement due by 4/16/2021. (ecS, COURT STAFF)
|
|
| 18 | 18
ORDER REASSIGNING CASE. Case reassigned to Judge Susan Illston for all further proceedings. Magistrate Judge Donna M. Ryu no longer assigned to case, Notice: The assigned judge participates in the Cameras in the Courtroom Pilot Project. See General Order No. 65 and http://cand.uscourts.gov/cameras.Signed by the Clerk on 1/21/2021.(anjS, COURT STAFF)
|
|
|
Att: 1
Notice of Eligibility for Video Recording
|
||
| Wednesday, January 20, 2021 | ||
| 17 | 17
AMENDED ORDER RELATING CASE. Signed by Judge Susan Illston on 1/20/2021. (ecS, COURT STAFF)
|
|
| 15 | 15
CLERK'S NOTICE Re: Consent or Declination: Plaintiff and Defendants shall file a consent or declination to proceed before a magistrate judge. Note that any party is free to withhold consent to proceed before a magistrate judge without adverse substantive consequences. The forms are available at: http://cand.uscourts.gov/civilforms. Consent/Declination due by 1/27/2021. (ig, COURT STAFF)
|
|
| 14 | 14
Rule 7.1 Disclosures by GlaxoSmithKline, LLC identifying Corporate Parent Glaxo Smithkline, plc for GlaxoSmithKline, LLC. (Tam, Jonathan)
|
|
| 13 | 13
Corporate Disclosure Statement by Sanofi-Aventis U.S. LLC identifying Corporate Parent Sanofi for Sanofi-Aventis U.S. LLC. (Mayo, Sharon)
|
|
| 12 | 12
Corporate Disclosure Statement by Sanofi US Services, Inc. identifying Corporate Parent Sanofi for Sanofi US Services, Inc.. (Mayo, Sharon)
|
|
| 11 | 11
NOTICE of Appearance by Tommy Huynh (Huynh, Tommy)
|
|
| 10 | 10
CERTIFICATE OF SERVICE by Boehringer Ingelheim Pharmaceuticals, Inc., Boehringer Ingelheim USA Corporation, Inc. re9 Notice (Other),8 Certificate of Interested Entities,7 Notice of Appearance (Blaschke, Matthew)
|
|
| 9 | 9
NOTICE of Defendants' Administrative Motion to Consider Whether Cases Should be Related Pursuant to Civil L.R. 3-12 by Boehringer Ingelheim Pharmaceuticals, Inc., Boehringer Ingelheim USA Corporation, Inc., GlaxoSmithKline, LLC, Sanofi US Services, Inc., Sanofi-Aventis U.S. LLC(Blaschke, Matthew) Modified on 1/20/2021 (jmlS, COURT STAFF).
|
|
|
Att: 1
Exhibit 1 - Defendants' Administrative Motion to Consider Whether Cases Should Be Related
|
||
| 8 | 8
Rule 7.1 Disclosures by Boehringer Ingelheim Pharmaceuticals, Inc., Boehringer Ingelheim USA Corporation, Inc. identifying Corporate Parent Boehringer Ingelheim Corporation, Corporate Parent Boehringer Ingelheim USA Corporation for Boehringer Ingelheim Pharmaceuticals, Inc.. (Blaschke, Matthew)
|
|
| 7 | 7
NOTICE of Appearance by Matthew J. Blaschke (Blaschke, Matthew)
|
|
| 6 | 6
Initial Case Management Scheduling Order with ADR Deadlines: Case Management Statement due by 4/14/2021. Initial Case Management Conference set for 4/21/2021 01:30 PM in Oakland, Courtroom 4, 3rd Floor. (jmlS, COURT STAFF)
|
|
| [LINK:Electronic filing error] . NOTICE TO COUNSEL: Matthew J. Blaschke. The docket shows a different address from what is appearing on the document (dkt. #: 7 Notice of Appearance filed by Boehringer Ingelheim USA Corporation, Inc., Boehringer Ingelheim Pharmaceuticals, Inc.). Please update your personal profile on ECF. (jmlS, COURT STAFF) | ||
| [LINK:Electronic filing error] . No title Page. Certificates/Proofs of Service e-filed separately and not as an attachment, require a title page. Please refer to Civil Local Rules 3-4 re first page requirement. Re:10 Certificate of Service, filed by Boehringer Ingelheim USA Corporation, Inc., Boehringer Ingelheim Pharmaceuticals, Inc. (jmlS, COURT STAFF) | ||
| [LINK:Electronic filing error] . Judge initials are missing. Counsel need not re-file the document, but should reference the correct judge initials (DMR)on future filings. Re:10 Certif icate of Service, filed by Boehringer Ingelheim USA Corporation, Inc., Boehringer Ingelheim Pharmaceuticals, Inc.,15 Clerk's Notice re: Consent or Declination,11 Notice of Appearance filed by Sanofi US Services, Inc., Sanofi-Aventis U.S. LLC,12 Certificate of Interested Entities filed by Sanofi US Services, Inc.,8 Certificate of Interested Entities, filed by Boehringer Ingelheim USA Corporation, Inc., Boehringer Ingelheim Pharmaceuticals, Inc.,7 Notice of Appearance filed by Boehringer Ingelheim USA Corporation, Inc., Boehringer Ingelheim Pharmaceuticals, Inc.,13 Certificate of Interested Entities filed by Sanofi-Aventis U.S. LLC,14 Certificate of Interested Entities filed by GlaxoSmithKline, LLC,9 Notice (Other), filed by Sanofi US Services, Inc., GlaxoSmithKline, LLC, Boehringer Ingelheim USA Corporation, Inc., Sanofi-Aventis U.S. LLC, Boehringer Ingelheim Pharmaceuticals, Inc. (jmlS, COURT STAFF) | ||
| Tuesday, January 19, 2021 | ||
| 5 | 5
MOTION to Stay Proceedings Pending Transfer to the MDL filed by Boehringer Ingelheim Pharmaceuticals, Inc., Boehringer Ingelheim USA Corporation, Inc., GlaxoSmithKline, LLC, Sanofi US Services, Inc., Sanofi-Aventis U.S. LLC. Motion Hearing set for 2/25/2021 01:00 PM before Magistrate Judge Donna M. Ryu. Responses due by 2/2/2021. Replies due by 2/9/2021.(Tam, Jonathan)
|
|
|
Att: 1
Proposed Order
|
||
| 4 | 4
NOTICE of Appearance by Jonathan S. Tam for GlaxoSmithKline LLC (Tam, Jonathan)
|
|
| 3 | 3
CERTIFICATE OF SERVICE by Sanofi US Services, Inc., Sanofi-Aventis U.S. LLC re1 Notice of Removal, (Podsiadlo, Kathryn)
|
|
| 2 | 2 Case assigned to Magistrate Judge Donna M. Ryu. Counsel for plaintiff or the removing party is responsible for serving the Complaint or Notice of Removal, Summons and the assigned judge's standing orders and all other new case documents upon the opposing parties. For information, visit E-Filing A New Civil Case at http://cand.uscourts.gov/ecf/caseopening. Standing orders can be downloaded from the court's web page at www.cand.uscourts.gov/judges. Upon receipt, the summons will be issued and returned electronically. Counsel is required to send chambers a copy of the initiating documents pursuant to L.R. 5-1(e)(7). A scheduling order will be sent by Notice of Electronic Filing (NEF) within two business days. Consent/Declination due by 2/2/2021. (anjS, COURT STAFF) | |
| 1 | 1
NOTICE OF REMOVAL from Alameda County Superior Court. Their case number is HG20084493 with jury demand (no process). (Filing fee $402 receipt number 0971-15458946). Filed by Sanofi-Aventis U.S. LLC, Sanofi US Services, Inc..(Mayo, Sharon) Modified on 1/20/2021 (jmlS, COURT STAFF).
|
|
|
Att: 1
Exhibit A,
|
||
|
Att: 2
Civil Cover Sheet
|
||